« Back
Home /
SARS-CoV-2 Omicron BA.2 Variant Pseudovirus

SARS-CoV-2 Omicron BA.2 Variant Pseudovirus

Item no.	PRS-95-202-1.0mL
Manufacturer	ProSci
Amount	1.0 mL (0.5 mL x 2 vials) for two 96-well plates
Category	Infectious Diseases Viral Infections Coronavirus (COVID-19) Peptides & Proteins Recombinant Proteins
Type	Proteins Recombinant
Format	Liquid
Applications	NT
Specific against	other
Source	HEK293 cells
Dry ice	Yes
Sequence	Omicron Variant Spike BA.2 Met 1 - Cys 1251 (T19I, LPP24-26del, A27S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K)
NCBI	S
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Spike glycoprotein Receptor-binding domain,S glycoprotein,Spike protein,Omicron variant spike,Omicron variant pseudovirus,Omicron,pseudovirus reporter,reporter virus particle
Shipping Condition	Dry ice
Available
Manufacturer - Type	Pseudovirus
Manufacturer - Applications	Neutralization assay, Viral Infection
Shipping Temperature	Dry Ice
Storage Conditions	The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.
Background	SARS-CoV-2 Omicron Pseudovirus uses HIV pseudotyped with SARS-CoV-2 spike protein and a firefly luciferase reporter. This pseudovirus effectively infects human ACE2 overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.
By Type	Infectious Disease, COVID-19
Badges	New
Protein Gi #	1791269090
Buffer	DMEM/10% FBS
Application Note	Protocol: 1. Require BSL-2 or higher working environment 2. 5 μL per application (96-well plate) with at least 0.3 X 10⁶ RLU / well. 3. Avoid freezing and thawing cycle to ensure the titer of the pseudovirus. 4. This product is for Research Use only 5. Neutralization assay protocol is available
NCBI Official Name	Surface glycoprotein
NCBI Organism	Severe acute respiratory syndrome coronavirus 2
Manufacturer - Species	SARS-CoV-2 (COVID-19) Spike pseudovirus
By Species	Other
Manufacturer - Original species	Firefly luciferase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

PRS-95-202-1.0mL-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 1.0 mL (0.5 mL x 2 vials) for two 96-well plates

available

Delivery expected until 11/6/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer